tm
Seeing Is Believing
tm
Seeing Is Believing
IBRX is currently covered by 2 analysts with an average price target of $10.11. This is a potential upside of $7.7 (319.5%) from yesterday's end of day stock price of $2.41.
Immunitybio's activity chart (see below) currently has 22 price targets and 33 ratings on display. The stock rating distribution of IBRX is 22.22% HOLD and 77.78% BUY.
Analysts average stock forecasts to be materialized ratio is 56.36% with an average time for these price targets to be met of 202.75 days.
Highest price target for IBRX is $30, Lowest price target is $5, average price target is $17.5.
Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 25-Jul-2025. First documented stock forecast 16-May-2017.
Currently out of the existing stock ratings of IBRX, 4 are a HOLD (22.22%), 14 are a BUY (77.78%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$30
$27.54 (1119.51%)
$30
14 days ago
(25-Jul-2025)
0/14 (0%)
$27.14 (948.95%)
Hold
$5
$2.54 (103.25%)
$4.75
2 months 19 days ago
(20-May-2025)
5/11 (45.45%)
$2.1 (72.41%)
103
Buy
$5
$2.54 (103.25%)
$8
2 years 2 months 24 days ago
(15-May-2023)
2/2 (100%)
$1.78 (55.28%)
431
Sell
$0.8
$-1.66 (-67.48%)
$1.25
6 years 2 months 8 days ago
(31-May-2019)
4/5 (80%)
$-0.23 (-22.33%)
277
What is IBRX (Immunitybio) average time for price targets to be met?
Which analyst has the current highest performing score on IBRX (Immunitybio) with a proven track record?
Which analyst has the current lower performing score on IBRX (Immunitybio) with a proven track record?
Which analyst has the most public recommendations on IBRX (Immunitybio)?
Which analyst is the currently most bullish on IBRX (Immunitybio)?
Which analyst is the currently most reserved on IBRX (Immunitybio)?
